MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

AIMS Circulating microRNAs (miRNAs) may represent a novel class of biomarkers; therefore, we examined whether acute myocardial infarction (MI) modulates miRNAs plasma levels in humans and mice. METHODS AND RESULTS Healthy donors (n = 17) and patients (n = 33) with acute ST-segment elevation MI (STEMI) were evaluated. In one cohort (n = 25), the first plasma sample was obtained 517 ± 309 min a...

-MicroRNAs: New biomarkers for diagnosing HIV-

According to the increasing number of AIDS patients and their deaths, Treatment is a very important debate to prevent this Which is dependent on early and Accurate diagnosis. Currently, there are different diagnostic methods, including virus cultures, rapid tests, western blot, and other tests for this infection. Among these, HIV RNA TESTING, especially APTIMA HIV RNA ASSAY and fourth generatio...

Circulating microRNAs are promising novel biomarkers of acute myocardial infarction.

OBJECTIVE Recent studies have revealed that microRNAs (miRNAs) are involved in the regulation of cardiac development, physiologic, and pathologic processes via post-transcriptional control of gene expression. The stable circulating miRNAs offer unique opportunities for the early diagnosis of several diseases. In this study, we examined the circulating miR-133 and miR-328 levels from patients wi...

Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

Infantile hemangioma (IH) is the most common vascular tumor of infancy, and it uniquely regresses in response to oral propranolol. MicroRNAs (miRNAs) have emerged as key regulators of vascular development and are dysregulated in many disease processes, but the role of miRNAs in IH growth has not been investigated. We report expression of C19MC, a primate-specific megacluster of miRNAs expressed...

MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p.